✦ LIBER ✦

PGI37 FACTORS ASSOCIATED WITH THE USE OF ENTERAL AND PARENTERAL PROTON PUMP INHIBITOR USE IN CRITICALLY ILL PATIENTS

✍ Scribed by J Sankaranarayanan; KM Olsen; T Reardon; EM Hays; LA Orwe

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Proton Pump Inhibitor Use and Risk of Hi

✍ James A. Kaye; Hershel Jick 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Proton pump inhibitor omeprazole use is

✍ A. Kirkpantur; B. Altun; M. Arici; C. Turgan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

Overuse, Costs and Complications Associa

✍ Mendoza Ladd, Antonio H. ;Mar, Nataliya ;Cohen, Joshua ;Graham, Robert 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Outbreak of gastric mucormycosis associa

✍ Enrique Maraví-Poma; JuanL. Rodríguez-Tudela; JesúsGarcía Jalón; Alfonso Manriqu 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 242 KB

PGI26 PATIENT CHARACTERISTICS ASSOCIATED

✍ J. Sankaranarayanan; T. Reardon; K.M. Olsen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

148 PROTON PUMP INHIBITOR USE IS ASSOCIA

✍ J.S. Bajaj; M. Tannous; Z. Bootwala; A.J. Sanyal; D.M. Heuman 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB